2026年全球血管再生設備市場報告

近年來，重組醫療設備市場規模持續強勁成長。預計該市場規模將從2025年的38.8億美元成長至2026年的42.4億美元，複合年成長率達9.3%。這一成長主要歸因於冠狀動脈疾病盛行率的上升、全球人口老化、導管介入檢查室的擴建、藥物釋放型支架的廣泛應用以及心臟介入技術的進步。

預計未來幾年重組器械市場規模將強勁成長，年複合成長率（CAGR）將達到9.5%，2030年將達到61億美元。預測期內的成長要素包括：精準血管介入治療的普及、微創手術需求的成長、人工智慧介入成像技術的整合、門診手術中心的擴張以及對生物可吸收支架和新一代支架的日益關注。預測期內的關鍵趨勢包括：微創血運重建手術的普及、生物可吸收支架在血管修復中的應用、先進的影像引導血管介入治療、經橈動脈入路心血管手術的增加以及門診病人血管護理模式的轉變。

心血管疾病盛行率的上升預計將推動重組器械市場的成長。心血管疾病（CVD）是指一系列影響心臟和血管的疾病，包括冠狀動脈疾病、中風、心臟衰竭和高血壓等。心血管疾病盛行率的上升主要是由於不健康的生活方式，這些生活方式會對心臟健康產生負面影響，並增加心臟相關疾病的風險。重組器械透過恢復和改善阻塞或狹窄動脈的血流，從而減少缺血並預防心肌梗塞和中風等併發症，為心血管疾病的治療做出貢獻。例如，根據英國區域醫療中心聯合戰略需求評估機構2025年3月發布的報告，2023年心血管疾病死亡人數為185人，高於2022年的178人。因此，心血管疾病盛行率的上升正在推動血管重建器械市場的成長。

在血管重建器械市場中，領導企業正致力於開發創新產品，例如新一代中間導管，以改善血管通路，提高血栓切除術的效率，並提升微創中風治療的成功率。中間導管是一種柔韌的大口徑醫療設備，用於血管內手術，引導其穿過腦血管和周邊血管，便於血栓抽吸和治療器械的輸送，並支持急性缺血性腦中風患者的快速重組。例如，2024年2月，美國神經血管醫療設備製造商Cerenovus公司發表了Cerenovus 71中間導管，該導管專為急性缺血性腦中風患者的重組設計。該器械具有大口徑，可高效進行血栓切除；具有出色的柔軟性，可輕鬆穿過彎曲血管；其壁結構最佳化了支撐和輸送之間的平衡。其目的是提高機械取栓手術的效率，並支持在時間緊迫的中風治療環境中實現更快的再灌注。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球血管再生設備市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 清單：主要原料、資源和供應商
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章：全球市場趨勢與策略

• 關鍵科技與未來趨勢
  • 生物技術、基因組學和精準醫療
  • 人工智慧和自主智慧
  • 工業4.0和智慧製造
  • 物聯網、智慧基礎設施、互聯生態系統
  • 數位化、雲端運算、巨量資料、網路安全
• 主要趨勢
  • 微創血管重組手術的擴展
  • 生物可吸收支架在血管修復的應用現況
  • 先進的影像導引血管介入治療
  • 基於橈動脈入路的心血管治療發展
  • 過渡到門診血管治療

第5章 終端用戶產業市場分析

• 醫院
• 心臟導管檢查室
• 門診手術中心
• 循環系統專科診所
• 研究和學術機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球血管再生設備市場：PESTEL 分析
• 全球血管再生設備市場：規模、對比及成長率分析
• 全球血管再生設備市場表現：規模與成長，2020-2025年
• 全球血管再生設備市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

• 依產品類型
• 無菌器械、球囊血管成形術導管、裸金屬支架、藥物塗層球囊、藥物釋放型支架、Everolimus洗脫支架
• 材料類型
• 生物可吸收支架、金屬、鈷鉻合金、鉑鉻合金、不鏽鋼、聚合物
• 透過使用
• 冠狀動脈介入治療、周邊血管介入治療、神經血管介入治療、腎臟動脈介入治療
• 最終用戶
• 醫院、心臟導管介入檢查室、專科循環系統診所、研究和學術機構
• 按類型細分：動脈粥狀硬化斑塊切除術硬化切除裝置
• 旋轉式動脈粥狀硬化斑塊切除術裝置、定向動脈動脈粥狀硬化斑塊切除術裝置、軌道式動脈動脈粥狀硬化斑塊切除術裝置、雷射動脈動脈粥狀硬化斑塊切除術裝置
• 按類型細分：球囊血管成形術導管
• 半順應性球囊導管、非順應性球囊導管、切割型球囊導管、刮痕型球囊導管
• 按類型細分：裸金屬支架
• 鈷鉻合金裸金屬支架、不鏽鋼裸金屬支架、鎳鈦合金裸金屬支架、自膨式裸金屬支架、球囊擴張型裸金屬支架
• 按類型細分：藥物塗層球囊
• 紫杉醇塗層球囊、Sirolimus塗層球囊、雙藥塗層球囊、聚合物塗層球囊、非聚合物塗層球囊
• 按類型細分：藥物釋放型支架
• 第一代藥物釋放型支架、第二代藥物釋放型支架、聚合物基藥物釋放型支架、可生物分解聚合物藥物釋放型支架、無聚合物藥物釋放型支架
• 按類型細分：Everolimus洗脫支架
• 耐久聚合物Everolimus洗脫支架、無聚合物Everolimus洗脫支架、生物可吸收支架Everolimus洗脫支架、薄壁支架型Everolimus洗脫支架

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 血管再生設備市場：競爭格局及市場佔有率（2024年）
• 血管再生設備市場：公司評估矩陣
• 血管再生設備市場：公司概況
  • Johnson & Johnson
  • Abbott Laboratories
  • Medtronic plc
  • Boston Scientific Corporation
  • Becton Dickinson and Company

第37章 其他大型企業和創新企業

• Stryker Corporation, Terumo Corporation, WL Gore & Associates Inc., Cook Medical LLC, Teleflex Incorporated, Asahi Intec Co. Ltd., MicroPort Scientific Corporation, Biotronik SE & Co. KG, Penumbra Inc., Lepu Medical Technology Co Ltd., Merit Medical Systems Inc., AngioDynamics Inc., Cordis Corporation, MicroVention Inc., OrbusNeich Medical Company Limited

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

• 2030年血管再生設備市場：提供新機會的國家
• 血管再生設備市場展望（2030）：蘊藏新機會的細分市場
• 血管再生設備市場展望（2030 年）：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第42章附錄

Revascularization devices are medical technologies intended to restore or enhance circulation in blood vessels that have become narrowed or obstructed. These devices are frequently utilized in the treatment of conditions such as coronary artery disease and peripheral artery disease. They function by reopening blocked vessels or creating alternative pathways around obstructions, ensuring sufficient delivery of oxygenated blood to tissues and organs.

The primary product categories of revascularization devices include atherectomy devices, balloon angioplasty catheters, bare metal stents, drug-coated balloons, drug-eluting stents, and everolimus-eluting stents. Atherectomy devices are minimally invasive medical tools designed to remove plaque accumulation from blood vessels and improve blood circulation. These devices are produced using materials such as bioabsorbable scaffolds, metallic materials, cobalt chromium, platinum chromium, stainless steel, and polymers. Their applications include coronary interventions, peripheral vascular interventions, neurovascular interventions, and renal artery interventions, and they are employed by hospitals, cardiac catheterization laboratories, ambulatory surgical centers, specialty cardiovascular clinics, and research and academic institutions.

Tariffs are influencing the revascularization devices market by increasing the cost of imported medical-grade components such as stent platforms, balloon catheter assemblies, imaging-compatible metals, and polymer-based drug delivery systems used in cardiovascular interventions. This is leading to higher procedural costs and procurement pressure on healthcare systems, particularly in import-dependent regions such as Asia-Pacific and parts of Latin America where advanced interventional cardiology devices are heavily sourced from global manufacturers. Hardware-intensive segments like drug-eluting stents, atherectomy devices, and advanced balloon angioplasty catheters are most affected due to complex global supply chains and reliance on precision manufacturing hubs in North America and Europe. However, tariffs are also promoting localized manufacturing of vascular devices, strengthening regional MedTech ecosystems, and encouraging companies to diversify suppliers and invest in cost-optimized innovation for long-term market resilience.

The revascularization device market size has grown strongly in recent years. It will grow from $3.88 billion in 2025 to $4.24 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising prevalence of coronary artery disease, growing aging population globally, expansion of catheterization laboratories, increasing adoption of drug eluting stents, improvements in interventional cardiology techniques.

The revascularization device market size is expected to see strongly grown in the next few years. It will grow to $6.1 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to growth in precision guided vascular interventions, rising demand for minimally invasive surgeries, integration of ai assisted interventional imaging, expansion of ambulatory surgical centers, increasing focus on bioresorbable and next generation stents. Major trends in the forecast period include minimally invasive revascularization procedures expansion, bioresorbable scaffold adoption in vascular repair, advanced imaging guided vascular interventions, radial access based cardiovascular procedures growth, outpatient shift toward ambulatory vascular treatment.

The rising prevalence of cardiovascular diseases is expected to propel the growth of the revascularization device market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, stroke, heart failure, and hypertension. The rising prevalence of cardiovascular diseases is primarily due to unhealthy lifestyles, which negatively affect heart health and increase the risk of developing heart-related disorders. Revascularization device helps in cardiovascular diseases by restoring and improving blood flow through blocked or narrowed arteries, thereby reducing ischemia and preventing complications such as heart attack and stroke. For instance, in March 2025, according to the Joint Strategic Needs Assessment, a UK-based community health center, the number of deaths caused by cardiovascular disease (CVD) was 185 in 2023, compared to 178 recorded in 2022. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the revascularization device market.

Key companies operating in the revascularization device market are focusing on the development of innovative products, such as next-generation intermediate catheters, to enhance blood vessel access, improve clot retrieval efficiency, and increase procedural success rates in minimally invasive stroke interventions. Intermediate catheters are flexible, large-lumen medical devices used during endovascular procedures to navigate cerebral and peripheral vasculature, facilitate aspiration or delivery of treatment devices, and support rapid revascularization in patients experiencing acute ischemic stroke. For example, in February 2024, Cerenovus Inc., a US-based neurovascular company, introduced the Cereglide 71 Intermediate Catheter designed for revascularization in patients with acute ischemic stroke. The device features a large inner lumen to support efficient clot removal, enhanced flexibility for navigation through tortuous vessels, and optimized wall construction to balance support and deliverability. It is intended to improve procedural efficiency in mechanical thrombectomy procedures and support faster reperfusion outcomes in time-critical stroke care scenarios.

In September 2024, Boston Scientific Corporation, a US-based medical technology company, acquired Silk Road Medical for $1.18 billion. With this acquisition, Boston Scientific aimed to strengthen its neurovascular and stroke intervention portfolio by expanding into transcarotid artery revascularization (TCAR) technologies and accelerating its presence in the carotid artery disease treatment space. Silk Road Medical Inc. is a US-based company focused on developing revascularization devices for the treatment of carotid artery disease.

Major companies operating in the revascularization device market are Johnson & Johnson; Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Becton Dickinson and Company; Stryker Corporation; Terumo Corporation; W. L. Gore & Associates Inc.; Cook Medical LLC; Teleflex Incorporated; Asahi Intec Co. Ltd.; MicroPort Scientific Corporation; Biotronik SE & Co. KG; Penumbra Inc.; Lepu Medical Technology Co Ltd.; Merit Medical Systems Inc.; AngioDynamics Inc.; Cordis Corporation; MicroVention Inc.; OrbusNeich Medical Company Limited; Meril Life Sciences Pvt. Ltd.; Acotec Scientific Holdings Limited; Zylox-Tonbridge Medical Technology Co Ltd.; iVascular S.L.U.

North America was the largest region in the revascularization device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the revascularization device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the revascularization device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The revascularization device market consists of sales of thrombectomy devices, embolic protection devices, intravascular imaging systems, vascular closure devices, and guiding catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The revascularization device market research report is one of a series of new reports from The Business Research Company that provides revascularization device market statistics, including revascularization device industry global market size, regional shares, competitors with a revascularization device market share, detailed revascularization device market segments, market trends and opportunities, and any further data you may need to thrive in the revascularization device industry. This revascularization device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Revascularization Device Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses revascularization device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for revascularization device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The revascularization device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Atherectomy Devices; Balloon Angioplasty Catheters; Bare Metal Stents; Drug Coated Balloons; Drug Eluting Stents; Everolimus Eluting Stents
• 2) By Material Type: Bioabsorbable Scaffold; Metallic; Cobalt Chromium; Platinum Chromium; Stainless Steel; Polymer
• 3) By Application: Coronary Interventions; Peripheral Vascular Interventions; Neurovascular Interventions; Renal Artery Interventions
• 4) By End User: Hospitals; Cardiac Catheterization Laboratories; Ambulatory Surgical Centers; Specialty Cardiovascular Clinics; Research And Academic Institutes
• Subsegments:
• 1) By Atherectomy Devices: Rotational Atherectomy Devices; Directional Atherectomy Devices; Orbital Atherectomy Devices; Laser Atherectomy Devices
• 2) By Balloon Angioplasty Catheters: Semi Compliant Balloon Catheters; Non Compliant Balloon Catheters; Cutting Balloon Catheters; Scoring Balloon Catheters
• 3) By Bare Metal Stents: Cobalt Chromium Bare Metal Stents; Stainless Steel Bare Metal Stents; Nitinol Bare Metal Stents; Self Expanding Bare Metal Stents; Balloon Expandable Bare Metal Stents
• 4) By Drug Coated Balloons: Paclitaxel Coated Balloons; Sirolimus Coated Balloons; Dual Drug Coated Balloons; Polymer Based Drug Coated Balloons; Non Polymer Drug Coated Balloons
• 5) By Drug Eluting Stents: First Generation Drug Eluting Stents; Second Generation Drug Eluting Stents; Polymer Based Drug Eluting Stents; Biodegradable Polymer Drug Eluting Stents; Polymer Free Drug Eluting Stents
• 6) By Everolimus Eluting Stents: Durable Polymer Everolimus Eluting Stents; Polymer Free Everolimus Eluting Stents; Bioresorbable Scaffold Everolimus Eluting Stents; Thin Strut Everolimus Eluting Stents
• Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Becton Dickinson and Company; Stryker Corporation; Terumo Corporation; W. L. Gore & Associates Inc.; Cook Medical LLC; Teleflex Incorporated; Asahi Intec Co. Ltd.; MicroPort Scientific Corporation; Biotronik SE & Co. KG; Penumbra Inc.; Lepu Medical Technology Co Ltd.; Merit Medical Systems Inc.; AngioDynamics Inc.; Cordis Corporation; MicroVention Inc.; OrbusNeich Medical Company Limited; Meril Life Sciences Pvt. Ltd.; Acotec Scientific Holdings Limited; Zylox-Tonbridge Medical Technology Co Ltd.; iVascular S.L.U.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Revascularization Device Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Revascularization Device Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Revascularization Device Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Revascularization Device Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Digitalization, Cloud, Big Data & Cybersecurity
• 4.2. Major Trends
  • 4.2.1 Minimally Invasive Revascularization Procedures Expansion
  • 4.2.2 Bioresorbable Scaffold Adoption In Vascular Repair
  • 4.2.3 Advanced Imaging Guided Vascular Interventions
  • 4.2.4 Radial Access Based Cardiovascular Procedures Growth
  • 4.2.5 Outpatient Shift Toward Ambulatory Vascular Treatment

5. Revascularization Device Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Cardiac Catheterization Laboratories
• 5.3 Ambulatory Surgical Centers
• 5.4 Specialty Cardiovascular Clinics
• 5.5 Research And Academic Institutes

6. Revascularization Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Revascularization Device Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Revascularization Device PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Revascularization Device Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Revascularization Device Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Revascularization Device Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Revascularization Device Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Revascularization Device Market Segmentation

• 9.1. Global Revascularization Device Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Atherectomy Devices, Balloon Angioplasty Catheters, Bare Metal Stents, Drug Coated Balloons, Drug Eluting Stents, Everolimus Eluting Stents
• 9.2. Global Revascularization Device Market, Segmentation By Material Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bioabsorbable Scaffold, Metallic, Cobalt Chromium, Platinum Chromium, Stainless Steel, Polymer
• 9.3. Global Revascularization Device Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Coronary Interventions, Peripheral Vascular Interventions, Neurovascular Interventions, Renal Artery Interventions
• 9.4. Global Revascularization Device Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Specialty Cardiovascular Clinics, Research And Academic Institutes
• 9.5. Global Revascularization Device Market, Sub-Segmentation Of Atherectomy Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Rotational Atherectomy Devices, Directional Atherectomy Devices, Orbital Atherectomy Devices, Laser Atherectomy Devices
• 9.6. Global Revascularization Device Market, Sub-Segmentation Of Balloon Angioplasty Catheters, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Semi Compliant Balloon Catheters, Non Compliant Balloon Catheters, Cutting Balloon Catheters, Scoring Balloon Catheters
• 9.7. Global Revascularization Device Market, Sub-Segmentation Of Bare Metal Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cobalt Chromium Bare Metal Stents, Stainless Steel Bare Metal Stents, Nitinol Bare Metal Stents, Self Expanding Bare Metal Stents, Balloon Expandable Bare Metal Stents
• 9.8. Global Revascularization Device Market, Sub-Segmentation Of Drug Coated Balloons, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Paclitaxel Coated Balloons, Sirolimus Coated Balloons, Dual Drug Coated Balloons, Polymer Based Drug Coated Balloons, Non Polymer Drug Coated Balloons
• 9.9. Global Revascularization Device Market, Sub-Segmentation Of Drug Eluting Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• First Generation Drug Eluting Stents, Second Generation Drug Eluting Stents, Polymer Based Drug Eluting Stents, Biodegradable Polymer Drug Eluting Stents, Polymer Free Drug Eluting Stents
• 9.10. Global Revascularization Device Market, Sub-Segmentation Of Everolimus Eluting Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Durable Polymer Everolimus Eluting Stents, Polymer Free Everolimus Eluting Stents, Bioresorbable Scaffold Everolimus Eluting Stents, Thin Strut Everolimus Eluting Stents

10. Revascularization Device Market Regional And Country Analysis

• 10.1. Global Revascularization Device Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Revascularization Device Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Revascularization Device Market

• 11.1. Asia-Pacific Revascularization Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Revascularization Device Market

• 12.1. China Revascularization Device Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Revascularization Device Market

• 13.1. India Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Revascularization Device Market

• 14.1. Japan Revascularization Device Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Revascularization Device Market

• 15.1. Australia Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Revascularization Device Market

• 16.1. Indonesia Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Revascularization Device Market

• 17.1. South Korea Revascularization Device Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Revascularization Device Market

• 18.1. Taiwan Revascularization Device Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Revascularization Device Market

• 19.1. South East Asia Revascularization Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Revascularization Device Market

• 20.1. Western Europe Revascularization Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Revascularization Device Market

• 21.1. UK Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Revascularization Device Market

• 22.1. Germany Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Revascularization Device Market

• 23.1. France Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Revascularization Device Market

• 24.1. Italy Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Revascularization Device Market

• 25.1. Spain Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Revascularization Device Market

• 26.1. Eastern Europe Revascularization Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Revascularization Device Market

• 27.1. Russia Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Revascularization Device Market

• 28.1. North America Revascularization Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Revascularization Device Market

• 29.1. USA Revascularization Device Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Revascularization Device Market

• 30.1. Canada Revascularization Device Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Revascularization Device Market

• 31.1. South America Revascularization Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Revascularization Device Market

• 32.1. Brazil Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Revascularization Device Market

• 33.1. Middle East Revascularization Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Revascularization Device Market

• 34.1. Africa Revascularization Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Revascularization Device Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Revascularization Device Market Regulatory and Investment Landscape

36. Revascularization Device Market Competitive Landscape And Company Profiles

• 36.1. Revascularization Device Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Revascularization Device Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Revascularization Device Market Company Profiles
  • 36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

37. Revascularization Device Market Other Major And Innovative Companies

• Stryker Corporation, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical LLC, Teleflex Incorporated, Asahi Intec Co. Ltd., MicroPort Scientific Corporation, Biotronik SE & Co. KG, Penumbra Inc., Lepu Medical Technology Co Ltd., Merit Medical Systems Inc., AngioDynamics Inc., Cordis Corporation, MicroVention Inc., OrbusNeich Medical Company Limited

38. Global Revascularization Device Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Revascularization Device Market

41. Revascularization Device Market High Potential Countries, Segments and Strategies

• 41.1 Revascularization Device Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Revascularization Device Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Revascularization Device Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer